What is the most likely diagnosis in a 22‑week pregnant woman presenting with progressive dyspnea on exertion or when supine, orthopnea, paroxysmal nocturnal dyspnea, persistent cough, fatigue, reduced exercise tolerance, peripheral edema, and occasional chest discomfort or palpitations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peripartum Cardiomyopathy (PPCM)

The most likely diagnosis in this 22-week pregnant woman presenting with progressive dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, persistent cough, fatigue, peripheral edema, and palpitations is peripartum cardiomyopathy (PPCM), though the timing is atypical since she is presenting during pregnancy rather than the more common postpartum period. 1

Clinical Reasoning

The constellation of symptoms described—dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, persistent cough, fatigue, reduced exercise tolerance, peripheral edema, and chest discomfort with palpitations—represents classic heart failure symptoms. While these can mimic normal physiological changes of pregnancy, their progressive nature and severity point toward pathologic cardiac dysfunction 1.

Why PPCM is the Leading Diagnosis

PPCM typically presents with NYHA class III or IV heart failure symptoms, and the clinical presentation described matches this pattern precisely 1. The European Society of Cardiology guidelines explicitly state that early signs and symptoms of PPCM include:

  • Pedal edema
  • Dyspnea on exertion
  • Orthopnea
  • Paroxysmal nocturnal dyspnea
  • Persistent cough
  • Praecordial pain and palpitations 1

Critical Timing Consideration

A key caveat: Only 9% of PPCM patients present in the last month of pregnancy, while 78% develop symptoms in the first 4 months after delivery 1. At 22 weeks gestation, this patient is presenting earlier than the typical PPCM timeframe. However, 13% of patients present either prior to 1 month before delivery or more than 4 months postpartum, indicating that atypical timing does occur 1.

Diagnostic Approach

The diagnosis requires:

  1. Echocardiographic confirmation showing:

    • LVEF < 45% or fractional shortening < 30%
    • Left ventricular end-diastolic diameter > 4.8 cm 1
  2. Exclusion of other causes of heart failure, as PPCM is a diagnosis of exclusion 1

  3. Absence of pre-existing heart disease before the last month of pregnancy 1

Important Differential Considerations

While PPCM is most likely, other critical diagnoses must be excluded:

  • Dilated cardiomyopathy (DCM): Can manifest during pregnancy when hemodynamic load increases, particularly in the first or second trimester. A family history of DCM would favor this diagnosis over PPCM 2

  • Ischemic cardiomyopathy: Though less common in young women, coronary artery disease can present with identical symptoms, as illustrated by case reports of young pregnant women with coronary disease mimicking PPCM 3

  • Physiologic dyspnea of pregnancy: Common and benign, but would not explain the full constellation of symptoms, particularly orthopnea, paroxysmal nocturnal dyspnea, and palpitations 4, 5

Clinical Pitfalls

The most dangerous pitfall is attributing these symptoms to normal pregnancy changes 1. The guidelines explicitly warn that women with PPCM and their healthcare providers often believe symptoms are due to normal pregnancy or general tiredness from recent childbirth. This delay in diagnosis can be life-threatening.

Red flags that distinguish pathologic from physiologic dyspnea include 4:

  • Paroxysmal nocturnal dyspnea
  • Anginal chest pain
  • Syncope
  • Anasarca
  • Diastolic heart murmurs

Risk Stratification

If LVEF is < 40%, this represents high risk requiring close monitoring in a tertiary center. If LVEF is < 20%, maternal mortality is very high 2. Additionally, left ventricular thrombosis occurs commonly in PPCM patients with LVEF < 35%, creating risk for catastrophic embolic events including stroke, coronary embolism, and mesenteric embolism 1.

Management Implications

This patient requires:

  • Immediate echocardiography to confirm diagnosis and assess severity
  • Interdisciplinary team management in a specialized center 2
  • Standard heart failure therapy adapted for pregnancy, respecting contraindications for certain medications 2
  • Anticoagulation consideration if LVEF < 35% or if intracardiac thrombus detected 2

Related Questions

What is the cause of a systolic flow murmur accompanied by tachycardia and mild hypertension in a pregnant woman?
In a patient with a one‑year history of dyspnea, orthopnea requiring two pillows, waking from sleep with air hunger (paroxysmal nocturnal dyspnea), a clear chest radiograph, denial of snoring or witnessed apneas, and decreased breath sounds on the right side, what is the most likely diagnosis?
In a 15‑year‑old male with persistent left lower‑quadrant abdominal tenderness and bruising, right‑sided back pain radiating to the ribs, and new left great‑toe stabbing pain with tingling after a recent appendectomy, what imaging studies and medical management are indicated?
How should a 24‑week pregnant woman with an 18‑lb weight gain be evaluated and managed?
What are the key principles of pre‑operative assessment and the recommended approach to common post‑operative complications according to Canadian guidelines?
What are the types of immune reconstitution inflammatory syndrome (IRIS) in patients with human immunodeficiency virus (HIV) infection?
What is the recommended size of the clear corneal wound for EVO (Implantable Collamer Lens) insertion?
What is the probability of developing pyoderma gangrenosum if a first-degree relative has the condition?
What is the minimum platelet count required to start therapeutic anticoagulation?
What are the possible symptoms of Epstein-Barr virus-positive lymphadenitis in a severely immunocompromised 45-year-old male being evaluated for primary central nervous system lymphoma?
How should ketonemia and ketonuria be evaluated and managed in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.